Employers split with PBMs to secure direct deals for cost-saving biosimilars

By Allison Bell

News November 21, 2025 at 06:24 PM

Share & Print

What You Need To Know

ERIC says the high cost of biologics is a problem even for big employers.
Some ERIC members are still deciding whether to break up with their PBMs over drugs like Humira.
Ohers are already moving on and forming relationships directly with biosimilar manufacturers.

More From HR Executive

NOT FOR REPRINT

© Arc, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.